The Impact of AI-enhanced Clinical Trials

Today’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They join Emerj Senior Editor Matthew DeMello on the program to talk about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore the extent that clinical trials are changing thanks to data, and how life sciences will change as more people seek clinical trials as a form of alternative care. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.